Oral cytobrush
OtherOral epithelial cells will be collected during routine odontology appointments, upon documented non-opposition, via minimally invasive cytobrush sampling of the inner cheek
NCT Number: NCT06094829
Head and neck cancers represent more than 500,000 cases per year worldwide, and often involve post-treatment relapse. The oral cavity is the most frequent site, but early disease stages are still insufficiently characterised and poorly detected. The study's aim is to better understand the oral mucosa somatic evolution, and how it can give rise to oral squamous cell carcinoma (OSCC).
This is a multi-centric, descriptive, non-interventional cohort in healthy adult subjects. The aim of the study is to detect the presence of OSCC driver gene mutations in healthy subjects' oral mucosa, quantify whether they provide cells with a selective advantage, and study the impact of tobacco and alcohol consumption on the mutational load. This study will not allow to identify potential malignant cells, and will be usable for diagnostic purposes.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Cabinet Libéral Picquendar, Bougival, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oral epithelial cells will be collected during routine odontology appointments, upon documented non-opposition, via minimally invasive cytobrush sampling of the inner cheek
Time frame: 12 months
Difference in mean number of non-synonymous mutations found in OSCC driver genes between smokers and non-smokers.
Hospices Civils de Lyon
Other
Acronym: DEMO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03336606
Carcinoma, Carcinoma, Squamous Cell
Portland, Oregon, United States
View Trial DetailsNCT02281955
Carcinoma, Carcinoma, Squamous Cell
Gainesville, Florida, United States
View Trial DetailsNCT01530997
Carcinoma, Carcinoma, Squamous Cell
Colorado Springs, Colorado, United States
View Trial DetailsNCT03077243
Carcinoma, Carcinoma, Squamous Cell
Gainesville, Florida, United States
View Trial Details